Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Tuberculosis Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.8% during the forecast period.
This report presents the market size and development trends by detailing the Tuberculosis Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Tuberculosis Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Tuberculosis Diagnostics industry and will help you to build a panoramic view of the industrial development.
Tuberculosis Diagnostics Market, By Type:
Culture-based
Sputum Smear Microscopy
Rapid Molecular
Others
Tuberculosis Diagnostics Market, By Application:
Hospital
Diagnostic Laboratories
Others
Some of the leading players are as follows:
Hain Lifescience
Epistem
Akonni Biosystems
Creative Diagnostics
BD
Roche
Danaher
Qiagen
Oxford Immunotec
Hologic
Abbott
BioMerieux
Thermo Fisher Scientific
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Tuberculosis Diagnostics Market: Technology Type Analysis
-
4.1 Tuberculosis Diagnostics Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Tuberculosis Diagnostics Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Culture-based
4.3.2 Sputum Smear Microscopy
4.3.3 Rapid Molecular
4.3.4 Others
5 Tuberculosis Diagnostics Market: Product Analysis
-
5.1 Tuberculosis Diagnostics Product Market Share Analysis, 2018 & 2026
-
5.2 Tuberculosis Diagnostics Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Tuberculosis Diagnostics Market: Application Analysis
-
6.1 Tuberculosis Diagnostics Application Market Share Analysis, 2018 & 2026
-
6.2 Tuberculosis Diagnostics Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital
6.3.2 Diagnostic Laboratories
6.3.3 Others
7 Tuberculosis Diagnostics Market: Regional Analysis
-
7.1 Tuberculosis Diagnostics Regional Market Share Analysis, 2018 & 2026
-
7.2 Tuberculosis Diagnostics Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Hain Lifescience
9.1.1 Hain Lifescience Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Epistem
9.2.1 Epistem Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Akonni Biosystems
9.3.1 Akonni Biosystems Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Creative Diagnostics
9.4.1 Creative Diagnostics Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 BD
9.5.1 BD Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Roche
9.6.1 Roche Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Danaher
9.7.1 Danaher Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Qiagen
9.8.1 Qiagen Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Oxford Immunotec
9.9.1 Oxford Immunotec Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Hologic
9.10.1 Hologic Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Abbott
9.11.1 Abbott Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 BioMerieux
9.12.1 BioMerieux Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Thermo Fisher Scientific
9.13.1 Thermo Fisher Scientific Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
The List of Tables and Figures (Totals 90 Figures and 143 Tables)
Figure Culture-based Tuberculosis Diagnostics market, 2015 - 2026 (USD Million)
Figure Sputum Smear Microscopy Tuberculosis Diagnostics market, 2015 - 2026 (USD Million)
Figure Rapid Molecular Tuberculosis Diagnostics market, 2015 - 2026 (USD Million)
Figure Others Tuberculosis Diagnostics market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Diagnostic Laboratories market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Tuberculosis Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table North America Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table North America Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table North America Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Canada Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Canada Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Europe Tuberculosis Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Europe Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Europe Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Europe Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Germany Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Germany Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table France Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table France Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Italy Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Italy Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Spain Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Spain Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Tuberculosis Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table China Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table China Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Japan Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Japan Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table India Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table India Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Tuberculosis Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table MEA Tuberculosis Diagnostics market, by country, 2015 - 2026 (USD Million)
-
Table MEA Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table MEA Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table MEA Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Tuberculosis Diagnostics market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Tuberculosis Diagnostics market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Tuberculosis Diagnostics market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Hain Lifescience Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Epistem Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Akonni Biosystems Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Creative Diagnostics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BD Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Danaher Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Qiagen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Oxford Immunotec Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hologic Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioMerieux Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
